Showing results (11-20 of 365) with videos related to
Sort By:
Pageof 37
Translational Lung Cancer Research|March 26, 2015
HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approachesAna Christina Garrido-Castro, Enriqueta FelipExpert Opinion on Emerging Drugs|September 19, 2007
Emerging drugs for non-small-cell lung cancerEnriqueta Felip, Mariacarmela Santarpia, Rafael RosellLung Cancer (Amsterdam, Netherlands)|October 11, 2007
How could pharmacogenomics help improve patient survival?Rafael Rosell, Enriqueta Felip, Luis Paz-AresTranslational Lung Cancer Research|December 21, 2019
Epidermal growth factor receptor first generation tyrosine-kinase inhibitorsAlex Martinez-Marti, Alejandro Navarro, Enriqueta FelipExpert Opinion on Investigational Drugs|September 6, 2014
Ganitumab for the treatment of small-cell lung cancerPablo Martínez, Paula Alexandra Sales Fidalgo, Enriqueta FelipCritical Reviews in Oncology/Hematology|June 3, 2020
New therapeutic approaches to overcoming resistant EGFR exon 20 alterationsAlex M Li, Amélie Boichard, Enriqueta Felip, et al.Pulmonary Therapy|June 13, 2023
Symptoms and Experiences with Small Cell Lung Cancer: A Mixed Methods Study of Patients and CaregiversD Gwyn Bebb, Cressida Murray, Andromachi Giannopoulou, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Women in oncology: progress, challenges, and keys to successKatherine Reeder-Hayes, Enriqueta Felip, Debra Patt, et al.Molecular Oncology|December 23, 2011
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancerRodrigo Dienstmann, Sara De Dosso, Enriqueta Felip, et al.Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Genetic testing for chemotherapy in non-small cell lung cancerRafael Rosell, Miquel Taron, Vicente Alberola, et al.Pageof 37